Page last updated: 2024-11-05

thalidomide and Spondylarthropathies

thalidomide has been researched along with Spondylarthropathies in 5 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Spondylarthropathies: Heterogeneous group of arthritic diseases sharing clinical and radiologic features. They are associated with the HLA-B27 ANTIGEN and some with a triggering infection. Most involve the axial joints in the SPINE, particularly the SACROILIAC JOINT, but can also involve asymmetric peripheral joints. Subsets include ANKYLOSING SPONDYLITIS; REACTIVE ARTHRITIS; PSORIATIC ARTHRITIS; and others.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Mens, LJJ1
van de Sande, MGH1
Baeten, DLP1
Krause, A1
Märker-Hermann, E1
Kehl, AS1
Corr, M1
Weisman, MH1
Sieper, J1
Lin, RJ1
Curran, JJ1
Zimmerman, TM1
Song, J1
Niewold, TB1
Sweiss, NJ1

Reviews

4 reviews available for thalidomide and Spondylarthropathies

ArticleYear
New treatment paradigms in spondyloarthritis.
    Current opinion in rheumatology, 2018, Volume: 30, Issue:1

    Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal,

2018
[Spondyloarthritis including psoriatic arthritis].
    Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:40

    Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Certolizumab Pegol; Comorbidity

2014
Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.
    Arthritis & rheumatology (Hoboken, N.J.), 2016, Volume: 68, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Autoimmunity; Bone Morphogen

2016
New treatment targets for axial spondyloarthritis.
    Rheumatology (Oxford, England), 2016, Volume: 55, Issue:suppl 2

    Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal,

2016

Other Studies

1 other study available for thalidomide and Spondylarthropathies

ArticleYear
Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2010, Volume: 16, Issue:2

    Topics: Adult; Antineoplastic Agents; Cryoglobulinemia; HLA-B27 Antigen; Humans; Lenalidomide; Lumbar Verteb

2010